Biomoleculesbiomolecules
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Metabolic Engineering of Escherichia Coli for Poly(3-Hydroxybutyrate)
Lin et al. Microb Cell Fact (2015) 14:185 DOI 10.1186/s12934-015-0369-3 RESEARCH Open Access Metabolic engineering of Escherichia coli for poly(3‑hydroxybutyrate) production via threonine bypass Zhenquan Lin1,2,3†, Yan Zhang1,2,3†, Qianqian Yuan1,2,3,4, Qiaojie Liu1,2,3, Yifan Li1,2,3, Zhiwen Wang1,2,3, Hongwu Ma4*, Tao Chen1,2,3,5* and Xueming Zhao1,2,3 Abstract Background: Poly(3-hydroxybutyrate) (PHB), have been considered to be good candidates for completely biode- gradable polymers due to their similar mechanical properties to petroleum-derived polymers and complete biodeg- radability. Escherichia coli has been used to simulate the distribution of metabolic fluxes in recombinant E. coli pro- ducing poly(3-hydroxybutyrate) (PHB). Genome-scale metabolic network analysis can reveal unexpected metabolic engineering strategies to improve the production of biochemicals and biofuels. Results: In this study, we reported the discovery of a new pathway called threonine bypass by flux balance analysis of the genome-scale metabolic model of E. coli. This pathway, mainly containing the reactions for threonine synthesis and degradation, can potentially increase the yield of PHB and other acetyl-CoA derived products by reutilizing the CO2 released at the pyruvate dehydrogenase step. To implement the threonine bypass for PHB production in E. coli, we deregulated the threonine and serine degradation pathway and enhanced the threonine synthesis, resulting in 2.23-fold improvement of PHB titer. Then, we overexpressed glyA to enhance the conversion of glycine to serine and activated transhydrogenase to generate NADPH required in the threonine bypass. -
Dispensing of Vitamin Products by Retail Pharmacies in South Africa: Implications for Dietitians
South African Journal of Clinical Nutrition 2016; 29(4):133–138 http://dx.doi.org/10.1080/16070658.2016.1219468 SAJCN ISSN 1607-0658 EISSN 2221-1268 Open Access article distributed under the terms of the © 2016 The Author(s) Creative Commons License [CC BY-NC 3.0] http://creativecommons.org/licenses/by-nc/3.0 RESEARCH Dispensing of vitamin products by retail pharmacies in South Africa: Implications for dietitians Ilse Trutera* and Liana Steenkampb a Department of Pharmacy, Drug Utilisation Research Unit (DURU), Nelson Mandela Metropolitan University, Port Elizabeth, South Africa b HIV & AIDS Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa *Corresponding author, email: [email protected] Objective: The objective of this study was to analyse the dispensing patterns of vitamins (Anatomical Therapeutic Chemical (ATC) group A11) over a one-year period in a group of community pharmacies in South Africa. Design and setting: A retrospective drug utilisation study was conducted on community pharmacy electronic dispensing records in South Africa recorded in 2013. Outcome measures: All products for ATC subgroup A11 were extracted and analysed. Results: A total of 164 233 vitamin products were dispensed to 84 805 patients (62.64% female patients). Males received on average 2.09 (SD = 2.63) vitamin products per year, compared to 1.84 (SD = 2.13) products for females. Ergocalciferol (A11CC01) was the most often dispensed (37.48% of all vitamin products), followed by plain Vitamin B-complex products (A11EA00) accounting for 32.77%. Ergocalciferol (vitamin D2) is only available on prescription (50 000 IU tablets or 50 000 IU/ml oily drops) in South Africa. -
Heterocyclic Chemistry Updated
1 | Page Heterocyclic Chemistry By Dr Vipul Kataria Definition: A heterocyclic compound or ring structure is a cyclic compound that has atoms of at least two different elements (N, O, S, P) as members of its ring. Introduction: Heterocyclic compounds may be defined as cyclic compounds having as ring members atoms of at least two different elements. It means the cyclic compound has one another atom different than carbon. Heterocyclic compounds have much importance in organic chemistry because of abundant presence of heterocyclic compounds in present pharmaceutical drugs. Like other organic compounds, there are several defined rules for naming heterocyclic compounds. IUPAC rules for nomenclature of heterocyclic systems (SPU 2012, 2 Marks) The system for nomenclature for heterocyclic systems was given by Hantzsch and Widman. The Hantzsch-Widman nomenclature is based on the type (Z) of the heteroatom; the ring size (n) and nature of the ring, whether it is saturated or unsaturated. This system of nomenclature applies to monocyclic 3-to-10-membered ring heterocycles. Type of the heteroatom: The type of heteroatom is indicated by a prefix as shown below for common hetreroatoms. Dr Vipul Kataria, Chemistry Department, V. P. & R. P. T. P. Science College, VV Nagar 2 | Pag e When two or more of the same heteroatoms are present, the prrefix di, tri, tetra… are used. e.g. dioxa, triaza, dithia. If the heteroatoms are different their atomic number in that grroup is considered. Thus order of numbering will be O, S, N, P, Si. Ring size: The ring size is indicated by a suffix according to Table I below. -
Folic Acid, Pyridoxine, and Cyanocobalamin Combination
ORIGINAL INVESTIGATION Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women The Women’s Antioxidant and Folic Acid Cardiovascular Study William G. Christen, ScD; Robert J. Glynn, ScD; Emily Y. Chew, MD; Christine M. Albert, MD; JoAnn E. Manson, MD Background: Observational epidemiologic studies indi- and visually significant AMD, defined as confirmed in- cate a direct association between homocysteine concentra- cident AMD with visual acuity of 20/30 or worse attrib- tion in the blood and the risk of age-related macular degen- utable to this condition. eration (AMD), but randomized trial data to examine the effect of therapy to lower homocysteine levels in AMD are Results:Afteranaverageof7.3yearsoftreatmentandfollow- lacking. Our objective was to examine the incidence of AMD up, there were 55 cases of AMD in the combination treat- in a trial of combined folic acid, pyridoxine hydrochloride ment group and 82 in the placebo group (relative risk, 0.66; (vitamin B6), and cyanocobalamin (vitamin B12) therapy. 95% confidence interval, 0.47-0.93 [P=.02]). For visually significant AMD, there were 26 cases in the combination Methods: We conducted a randomized, double-blind, treatment group and 44 in the placebo group (relative risk, placebo-controlled trial including 5442 female health care 0.59; 95% confidence interval, 0.36-0.95 [P=.03]). professionals 40 years or older with preexisting cardio- vascular disease or 3 or more cardiovascular disease risk Conclusions: These randomized trial data from a large factors. A total of 5205 of these women did not have a cohort of women at high risk of cardiovascular disease diagnosis of AMD at baseline and were included in this indicate that daily supplementation with folic acid, pyri- analysis. -
Applications
TN-1175 APPLICATIONS Xianrong (Jenny) Wei A Simple and Effective Method for HPLC Quantification Jenny is a Senior Scientist in Phenomenex’s PhenoLogix of Simultaneous Vitamin B1 (Thiamine Diphosphate) and applications laboratory. Vitamin B6 (Pyridoxal 5-Phosphate) from Whole Blood Xianrong (Jenny) Wei, Sean Orlowicz, Erica Pike, and Brian Rivera Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA Abstract The purpose of this experiment was to develop a simple and ro- 2. 25 % NaOH was prepared by adding 10 mL of 50 % NaOH to bust method for the simultaneous analysis of biologically active 10 mL DI Water. Vitamin B1 (TDP) and Vitamin B6 (PLP) from whole blood. 3. 25 mM Na2HPO4 (pH 7) was prepared by adding 6.7 g of Na2HPO4.7H2O to 1 L of DI water. pH was adjusted with 85 % Introduction H3PO4. Water-soluble B Vitamins are important cofactors in cell metabo- 4. 250/250 mg/mL semicarbazide/glycine was prepared by lism. Two water-soluble vitamins with clinical relevance are Vita- adding 500 mg of semicarbazide and 500 mg of glycine to mins B1 and B6. Thiamine Diphosphate (TDP) is the biologically 2 mL of DI water. active form of Vitamin B1 and is required for various metabolic functions. Prolonged deficiency can cause beriberi, a debilitating Sample Preparation neurological disease1. Pyridoxal 5-phosphate (PLP) is the biolog- All extraction steps were performed while protecting the sam- ically active form of Vitamin B6 and is a coenzyme for a number ple from light and under cold conditions, such as on ice. Human of transamination reactions. -
Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
nutrients Article Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women Pramod B. Umarji 1, Pankaj Verma 2, Vivek Garg 2, Marian Schini 3,* and Richard Eastell 3 1 Umarji Healthcare, Pune, Maharashtra 411045, India; [email protected] 2 Hindustan Unilever Limited R&D, Gurugram, Haryana 122002, India; [email protected] (P.V.); [email protected] (V.G.) 3 Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S10 2NR, UK; r.eastell@sheffield.ac.uk * Correspondence: m.schini@sheffield.ac.uk; Tel.: +44-0114-215-9667 Abstract: Young Indian women may be at risk of poor bone health due to malnutrition. The aim of this study was to examine the effects on bone metabolism of a nutritional supplement in women aged 25 to 44. The nutritional supplement was a protein-rich beverage powder fortified with multi- micronutrients including calcium (600 mg), vitamin D (400 IU), and vitamin K (55 mcg) per daily serving, while a placebo supplement was low-protein non-fortified isocaloric beverage powder. This 6-month randomised, controlled trial showed favorable changes in bone turnover markers (decreased) and calcium homeostasis; such changes in older adults have been associated with slowing of bone loss and reduced fracture risk. For example, serum CTX decreased by about 30% and PINP by about 20% as a result of the increase in calcium intake. There were also changes in the ratio of carboxylated to undercarboxylated osteocalcin and such changes have been linked to a slowing of bone loss in older subjects. For example, the ratio increased by about 60% after 3 months as a result in the improvement in vitamin K status. -
Condensed Cyclic Compound, Composition Including The
(19) TZZ¥_ _T (11) EP 3 184 522 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 28.06.2017 Bulletin 2017/26 C07D 403/14 (2006.01) H01L 51/00 (2006.01) (21) Application number: 16205894.5 (22) Date of filing: 21.12.2016 (84) Designated Contracting States: • INAYAMA, Satoshi AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Yokohama-city, Kanagawa 230-0027 (JP) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • ISHII, Norihito PL PT RO RS SE SI SK SM TR Yokohama-city, Kanagawa 230-0027 (JP) Designated Extension States: • SHIBATA, Katsunori BA ME Yokohama-city, Kanagawa 230-0027 (JP) Designated Validation States: • ITO, Mitsunori MA MD Yokohama-city, Kanagawa 230-0027 (JP) (30) Priority: 22.12.2015 JP 2015250531 (74) Representative: Scheuermann, Erik Elkington and Fife LLP (71) Applicant: Samsung Electronics Co., Ltd. Prospect House Gyeonggi-do 16677 (KR) 8 Pembroke Road Sevenoaks, Kent TN13 1XR (GB) (72) Inventors: • KATO, Fumiaki Yokohama-city, Kanagawa 230-0027 (JP) (54) CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE (57) A condensed cyclic compound, a composition including the condensed cyclic compound, an organic light-emit- ting device including the condensed cyclic compound, and a method of manufacturing the organic light-emitting device are provided. EP 3 184 522 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 184 522 A1 Description FIELD OF THE INVENTION 5 [0001] One or more embodiments relate to a condensed cyclic compound, a composition including the condensed cyclic compound, an organic light-emitting device including the condensed cyclic compound, and a method of manufac- turing the organic light-emitting device. -
Secretin and Autism: a Clue but Not a Cure
SCIENCE & MEDICINE Secretin and Autism: A Clue But Not a Cure by Clarence E. Schutt, Ph.D. he world of autism has been shaken by NBC’s broadcast connections could not be found. on Dateline of a film segment documenting the effect of Tsecretin on restoring speech and sociability to autistic chil- The answer was provided nearly one hundred years ago by dren. At first blush, it seems unlikely that an intestinal hormone Bayless and Starling, who discovered that it is not nerve signals, regulating bicarbonate levels in the stomach in response to a but rather a novel substance that stimulates secretion from the good meal might influence the language centers of the brain so cells forming the intestinal mucosa. They called this substance profoundly. However, recent discoveries in neurobiology sug- “secretin.” They suggested that there could be many such cir- gest several ways of thinking about the secretin-autism connec- culating substances, or molecules, and they named them “hor- tion that could lead to the breakthroughs we dream about. mones” based on the Greek verb meaning “to excite”. As a parent with more than a decade of experience in consider- A simple analogy might help. If the body is regarded as a commu- ing a steady stream of claims of successful treatments, and as a nity of mutual service providers—the heart and muscles are the pri- scientist who believes that autism is a neurobiological disorder, I mary engines of movement, the stomach breaks down foods for have learned to temper my hopes about specific treatments by distribution, the liver detoxifies, and so on—then the need for a sys- seeing if I could construct plausible neurobiological mechanisms tem of messages conveyed by the blood becomes clear. -
Organic Chemistry PEIMS Code: N1120027 Abbreviation: ORGCHEM Number of Credits That May Be Earned: 1/2-1
Course: Organic Chemistry PEIMS Code: N1120027 Abbreviation: ORGCHEM Number of credits that may be earned: 1/2-1 Brief description of the course (150 words or less): Organic chemistry is an introductory course that is designed for the student who intends to continue future study in the sciences. The student will learn the concepts and applications of organic chemistry. Topics covered include aliphatic and aromatic compounds, alcohols, aldehydes, ketones, acids, ethers, amines, spectra, and stereochemistry. A brief introduction into biochemistry is also provided. The laboratory experiments will familiarize the student with the important laboratory techniques, specifically spectroscopy. Traditional high school chemistry courses focus on the inorganic aspects of chemistry whereas organic chemistry introduces the student to organic compounds and their properties, mechanisms of formations, and introduces the student to laboratory techniques beyond the traditional high school chemistry curriculum. Essential Knowledge and Skills of the course: (a) General requirements. This course is recommended for students in Grades 11-12. The recommended prerequisite for this course is AP Chemistry. (b) Introduction. Organic chemistry is designed to introduce students to the fundamental concepts of organic chemistry and key experimental evidence and data, which support these concepts. Students will learn to apply these data and concepts to chemical problem solving. Additionally, students will learn that organic chemistry is still evolving by reading about current breakthroughs in the field. Finally, students will gain appreciation for role that organic chemistry plays in modern technological developments in diverse fields, ranging from biology to materials science. (c) Knowledge and skills. (1) The student will be able to write both common an IUPAC names for the hydrocarbon. -
AROMATIC COMPOUNDS Aromaticity
AROMATICITY AROMATIC COMPOUNDS Aromaticity Benzene - C6H6 H H H H H H H H H H H H Kekulé and the Structure of Benzene Kekule benzene: two forms are in rapid equilibrium 154 pm 134 pm • All bonds are 140 pm (intermediate between C-C and C=C) • C–C–C bond angles are 120° • Structure is planar, hexagonal A Resonance Picture of Bonding in Benzene resonance hybrid 6 -electron delocalized over 6 carbon atoms The Stability of Benzene Aromaticity: cyclic conjugated organic compounds such as benzene, exhibit special stability due to resonance delocalization of -electrons. Heats of hydrogenation + H2 + 120 KJ/mol + 2 H2 + 230 KJ/mol calc'd value= 240 KJ/mol 10 KJ/mol added stability + 3 H 2 + 208 KJ/mol calc'd value= 360 KJ/mol 152 KJ/mol added stability + 3 H2 + 337 KJ/mol 1,3,5-Hexatriene - conjugated but not cyclic Resonance energy of benzene is 129 - 152 KJ/mol An Orbital Hybridization View of Bonding in Benzene • Benzene is a planar, hexagonal cyclic hydrocarbon • The C–C–C bond angles are 120° = sp2 hybridized • Each carbon possesses an unhybridized p-orbital, which makes up the conjugated -system. • The six -electrons are delocalized through the -system The Molecular Orbitals of Benzene - the aromatic system of benzene consists of six p-orbitals (atomic orbitals). Benzene must have six molecular orbitals. Y6 Y4 Y5 six p-orbitals Y2 Y3 Y1 Degenerate orbitals: Y : zero nodes orbitals that have the 1 Bonding same energy Y2 and Y3: one node Y and Y : two nodes 4 5 Anti-bonding Y6: three node Substituted Derivatives of Benzene and Their Nomenclature -
The Role of Some of the Krebs Cycle Reactions in the Biosynthetic Functions of Thiobacillus Thioparus
AN ABSTRACT OF THE THESIS OF Gerald G. Still for the PhD in Chemistry (Name) (Degree) (Major) Date thesis is presented May 14, 1965 Title THE ROLE OF SOME OF THE KREBS CYCLE REACTIONS IN THE BIOSYNTHETIC FUNCTIONS OF THIOBACILLUS THIOPARUS Abstract approved Redacted for Privacy (Major professor) Aseptic radiorespirometry has been used to examine the utilization of external carbon sources by proliferat- ing Thiobacillus thioparus cells. These studies reveal that glucose, galactose, mannose, fructose, ribose, DL- glutamate, and L- aspartate were not utilized by this chemoautotrophic organism. However, it has been shown that trace amounts of acetate, glycine, DL- serine, DL- alanine, succinate and fumarate can be utilized by T. thioparus cells. To elucidate the nature of the biosynthetic pathways operative in this bacteria, proliferating cell cultures were allowed to metabolize specifically 14C labeled substrates. The resulting 14C labeled cells were sub- sequently hydrolyzed, their amino acids isolated and subjected to degradation experiments. Examination of the respective fates of the label in DL- alanine- 2 -14C, acetate- 1 -14C, or acetate -2 -14C in the cellular metabolism revealed that the Krebs Cycle path- way is not functioning as a respiratory mechanism in T. thioparus. However, most of the reactions of the Krebs Cycle pathway are involved in the biosynthesis of carbon skeletons for various amino acids. A CO2 fixa- tion pathway of the C3 +C1 type is instrumental in provid- ing C4 dicarboxylic acids and those amino acids derived therefrom. Acetate can be incorporated into a -keto- glutarate and those amino acids derived therefrom, but cannot be incorporated into the C4 dicarboxylic acids. -
Glucagon and Gastrointestinal Motility in Relation to Thyroid-Parathyroid Function
Upsala J Med Sci 77: 183-188, 1972 Glucagon and Gastrointestinal Motility in Relation to Thyroid-Parathyroid Function HENRY JOHANSSON and ANDERS SEGERSTROM From the Department of Surgery, University Hospital, Uppsala, Sweden ABSTRACT MATERIAL Gastrointestinal propulsive motility was studied after The material consisted of 109 male albino rats (Sprague- inhgastric deposition of a non-absorbable isotope in Dawley) fed on laboratory food and with free access to rats after subcutaneous glucagon injections. Glucagon water. The animals were distributed at random in fol- administration was followed by retardation of gastric lowing series: emptying. The results indicated that the retarding effect Series I of glucagon on gastrointestinal propulsion was independent The influence of glucagon on gastrointestinal motility in of the presence of both thyroid and parathyroid tissue. intact rats. The observation period was 7 days. The hypocalcemic effect of glucagon was exerted in- dependently of the presence of thyroid tissue, Le. thyro- 1. Intact rats given 1.2 mg glucagon/kg body weight calcitonin. (GN-A, n= 6) 2. Intact rats given 4.8 mg glucagon/kg body weight (GN-B, n= 5) 3. Intact rats given 9.6 mg glucagon/kg body weight INTRODUCTION (GN-C, n= 12) 4. Intact rats given glucine buffert (GLY, n= 10). Glucagon is known to influence gastrointestinal Series I1 motility. In man, Dotevall & Kock (2) observed The influence of glucagon on gastrointestinal motility in that glucagon retarded gastrointestinal motility parathyroidectomized rats. The animals were given 4.8 independently of the hyperglucemia. In dogs, mg glucagon/kg body weight. The observation period glucagon retarded motility of the stomach ani was 90 days.